Type 2 diabetes mellitus is associated with altered CD8+ T and natural killer cell function in pulmonary tuberculosis

Immunology

Volumn 144, Issue 4, 2015, Pages 677-686

  Kumar, Nathella P ^a,b   Sridhar, Rathinam ^c   Nair, Dina ^b   Banurekha, Vaithilingam V ^b   Nutman, Thomas B ^d   Babu, Subash ^a,d  

^a National Institute of Epidemiology   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c Government Stanley Hospital   (India)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CD8+ T cells; Diabetes; Natural killer cells; Tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MYCOBACTERIUM ANTIGEN; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL ANTIGEN; BIOLOGICAL MARKER; CYTOKINE;

ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE COUNT; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; CELL CULTURE; COMPLICATION; DIABETES MELLITUS, TYPE 1; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PHENOTYPE; PROGNOSIS; TUBERCULOSIS, PULMONARY;

ANTIGENS, BACTERIAL; BIOMARKERS; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 1; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PROGNOSIS; TUBERCULOSIS, PULMONARY;

EID: 84924370903     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12421     Document Type: Article

References (30)

1. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9:737-46.
2. Harries AD, Lin Y, Satyanarayana S et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 2011; 15:1436-44, i.
3. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5:e152.
4. Baker MA, Harries AD, Jeon CY et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011; 9:81.
5. Al-Attiyah RJ, Mustafa AS. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects. Clin Exp Immunol 2009; 158:64-73.
6. Stalenhoef JE, Alisjahbana B, Nelwan EJ et al. The role of interferon-γ in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 2008; 27:97-103.
7. Martinez N, Kornfeld H. Diabetes and immunity to tuberculosis. Eur J Immunol 2014; 44:617-26.
8. Restrepo BI, Schlesinger LS. Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis 2013; 93(Suppl.):S10-4.
9. Kumar NP, Sridhar R, Banurekha VV et al. Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann Am Thorac Soc 2013; 10:441-9.
10. Kumar NP, Sridhar R, Banurekha VV et al. Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis 2013; 208:739-48.
11. O'Garra A, Redford PS, McNab FW et al. The immune response in tuberculosis. Annu Rev Immunol 2013; 31:475-527.
12. Cullen SP, Martin SJ. Mechanisms of granule-dependent killing. Cell Death Differ 2008; 15:251-62.
13. Deepa M, Pradeepa R, Rema M et al. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003; 51:863-70.
14. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004; 22:599-623.
15. Vankayalapati R, Barnes PF. Innate and adaptive immune responses to human Mycobacterium tuberculosis infection. Tuberculosis 2009; 89(Suppl 1):S77-80.
16. Balakrishnan S, Vijayan S, Nair S et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One 2012; 7:e46502.
17. Viswanathan V, Kumpatla S, Aravindalochanan V et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One 2012; 7:e41367.
18. Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004; 27:1584-90.
19. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26:259-65.
20. Nikolajczyk BS, Jagannathan-Bogdan M, Shin H et al. State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun 2011; 12:239-50.
21. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41:1241-8.
22. Vallerskog T, Martens GW, Kornfeld H. Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol 2010; 184:6275-82.
23. Restrepo BI, Fisher-Hoch SP, Pino PA et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 2008; 47:634-41.
24. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27:393-422.
25. Lazarevic V, Glimcher LH. T-bet in disease. Nat Immunol 2011; 12:597-606.
26. Khader SA, Cooper AM. IL-23 and IL-17 in tuberculosis. Cytokine 2008; 41:79-83.
27. Torrado E, Cooper AM. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev 2010; 21:455-62.
28. Peters A, Lee Y, Kuchroo VK. The many faces of Th17 cells. Curr Opin Immunol 2011; 23:702-6.
29. Sell H, Habich C, Eckel J. Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 2012; 8:709-16.
30. Jagannathan-Bogdan M, McDonnell ME, Shin H et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 2011; 186:1162-72.